Name: Recombinant Anti-CD3 x Anti-GPNMB Bispecific Antibody (scIgG)
SKU: SCIGG-088
Rating: 5 (1 reviews)

Recombinant Anti-CD3 x Anti-GPNMB Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CD3 and anti-GPNMB IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can retarget T cells to tumor cells. It is designed for the research of Melanoma; Breast cancer therapy.

Datasheet INQUIRY

Specifications

Targets

CD3 & GPNMB

Type

Single chain IgGs

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Melanoma; Breast cancer

Host Animal 1

Mouse

Host Animal 2

Mouse

Targets

Target 1

CD3

Gene ID

916

UniProt ID

P07766

Alternative Names

CD3; CD3E; CD3e molecule; Cluster of differentiation 3; CD3e molecule, epsilon (CD3-TCR complex); T3E; TCRE; IMD18; T-cell surface glycoprotein CD3 epsilon chain; CD3-epsilon; T-cell surface antigen T3/Leu-4 epsilon chain; CD3e antigen, epsilon polypeptide (TiT3 complex); T-cell antigen receptor complex, epsilon subunit of T3

Target 2

GPNMB

Gene ID

93695

UniProt ID

Q99P91

Alternative Names

GPNMB; glycoprotein (transmembrane) nmb; ipd; Dchil; DC-HIL; transmembrane glycoprotein NMB; osteoactivin; iris pigment dispersion; dendritic cell-associated transmembrane protein; dendritic cell-associated heparin sulfate proteoglycan-dependent integrin ligand; Glycoprotein non-metastatic b

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-GPNMB Bispecific Antibody (scIgG) (SCIGG-088). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CD3 x Anti-GPNMB Bispecific Antibody (scIgG) (CAT#: SCIGG-088)

Specifications

Targets

Customer Reviews and Q&As